Literature DB >> 29105012

Is awake surgery for supratentorial adult low-grade gliomas the gold standard?

Michael Buchfelder1, Yining Zhao2.   

Abstract

Entities:  

Keywords:  Awake craniotomy; Functional neuronavigation; Glioma resection; Intraoperative imaging; Low-grade gliomas

Mesh：

Year:  2018        PMID： 29105012     DOI： 10.1007/s10143-017-0916-y

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN： 0344-5607            Impact factor:   3.042


× No keyword cloud information.
  10 in total

1.  Multimodal navigation integrated with imaging.

Authors:  Christopher Nimsky; Daniela Kuhnt; Oliver Ganslandt; Michael Buchfelder
Journal:  Acta Neurochir Suppl       Date:  2011

2.  Awake craniotomy to maximize glioma resection: methods and technical nuances over a 27-year period.

Authors:  Shawn L Hervey-Jumper; Jing Li; Darryl Lau; Annette M Molinaro; David W Perry; Lingzhong Meng; Mitchel S Berger
Journal:  J Neurosurg       Date:  2015-04-24       Impact factor: 5.115

3.  Intraoperative Magnetic Resonance Imaging in Intracranial Glioma Resection: A Single-Center, Retrospective Blinded Volumetric Study.

Authors:  Olutayo Ibukunolu Olubiyi; Aysegul Ozdemir; Fatih Incekara; Yanmei Tie; Parviz Dolati; Liangge Hsu; Sandro Santagata; Zhenrui Chen; Laura Rigolo; Alexandra J Golby
Journal:  World Neurosurg       Date:  2015-05-01       Impact factor: 2.104

4.  Contribution of combined intraoperative electrophysiological investigation with 3-T intraoperative MRI for awake cerebral glioma surgery: comprehensive review of the clinical implications and radiological outcomes.

Authors:  Diana Ghinda; Nan Zhang; Junfeng Lu; Cheng-Jun Yao; Shiwen Yuan; Jin-Song Wu
Journal:  Neurosurg Focus       Date:  2016-03       Impact factor: 4.047

5.  Intraoperative visualization for resection of gliomas: the role of functional neuronavigation and intraoperative 1.5 T MRI.

Authors:  Christopher Nimsky; Oliver Ganslandt; Michael Buchfelder; Rudolf Fahlbusch
Journal:  Neurol Res       Date:  2006-07       Impact factor: 2.448

6.  Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial.

Authors:  Christian Senft; Andrea Bink; Kea Franz; Hartmut Vatter; Thomas Gasser; Volker Seifert
Journal:  Lancet Oncol       Date:  2011-08-23       Impact factor: 41.316

7.  Quantification of glioma removal by intraoperative high-field magnetic resonance imaging: an update.

Authors:  Daniela Kuhnt; Oliver Ganslandt; Sven-Martin Schlaffer; Michael Buchfelder; Christopher Nimsky
Journal:  Neurosurgery       Date:  2011-10       Impact factor: 4.654

8.  Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance.

Authors:  Elizabeth B Claus; Andres Horlacher; Liangge Hsu; Richard B Schwartz; Donna Dello-Iacono; Florian Talos; Ferenc A Jolesz; Peter M Black
Journal:  Cancer       Date:  2005-03-15       Impact factor: 6.860

9.  Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology.

Authors:  Lonneke A M Gravendeel; Mathilde C M Kouwenhoven; Olivier Gevaert; Johan J de Rooi; Andrew P Stubbs; J Elza Duijm; Anneleen Daemen; Fonnet E Bleeker; Linda B C Bralten; Nanne K Kloosterhof; Bart De Moor; Paul H C Eilers; Peter J van der Spek; Johan M Kros; Peter A E Sillevis Smitt; Martin J van den Bent; Pim J French
Journal:  Cancer Res       Date:  2009-11-17       Impact factor: 12.701

Review 10.  Is non-awake surgery for supratentorial adult low-grade glioma treatment still feasible?

Authors:  Hugues Duffau
Journal:  Neurosurg Rev       Date:  2017-11-06       Impact factor: 3.042
  10 in total
  2 in total

1.  Awake mapping is not an additional surgical technique but an alternative philosophy in the management of low-grade glioma patients.

Authors:  Michael Buchfelder; Yining Zhao
Journal:  Neurosurg Rev       Date:  2018-03-02       Impact factor: 3.042

2.  Awake mapping is not an additional surgical technique but an alternative philosophy in the management of low-grade glioma patients.

Authors:  Hugues Duffau
Journal:  Neurosurg Rev       Date:  2017-12-13       Impact factor: 3.042
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.